Technical Analysis for DSNKY - Daiichi Sankyo Company, Limited

Grade Last Price % Change Price Change
grade A 68.59 1.31% 0.8900
DSNKY closed up 1.31 percent on Friday, August 16, 2019, on 74 percent of normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical DSNKY trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
New 52 Week High Strength 0.00%
Gapped Up Strength 0.00%
Overbought Stochastic Strength 0.00%
New 52 Week Closing High Bullish 1.31%
180 Bullish Setup Bullish Swing Setup 1.31%
Pocket Pivot Bullish Swing Setup 1.31%
Narrow Range Bar Range Contraction 1.31%
Gapped Up Strength 1.31%

Older signals for DSNKY ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Founded on September 28, 2005 through the merger of Daiichi Pharmaceutical and Sankyo, Daiichi Sankyo delivers innovative products that enhance the lives of millions of people around the world. Our recent successes include the antihypertensive agent olmesartan (Olmetec®), launched in 2002 by Sankyo and now available in more than 50 countries around the world; the antiplatelet agent prasugrel (Efient®), launched in 2009 for patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI); and edoxaban (Lixiana®), the first available factor Xa inhibitor in Japan, which launched in 2011 to help prevent venous thromboembolism (VTE).
Chemistry Chemical Compounds Organic Compounds Ketones Chloroarenes Eli Lilly And Company Acute Coronary Syndrome Cyclopropanes Venous Thromboembolism Anticoagulants Antiplatelet Drug Daiichi Sankyo Edoxaban Prasugrel
Is DSNKY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 68.78
52 Week Low 30.0
Average Volume 8,888
200-Day Moving Average 44.6745
50-Day Moving Average 58.2453
20-Day Moving Average 62.2351
10-Day Moving Average 65.7906
Average True Range 1.3983
ADX 32.78
+DI 49.2889
-DI 20.3214
Chandelier Exit (Long, 3 ATRs ) 64.5851
Chandelier Exit (Short, 3 ATRs ) 60.4349
Upper Bollinger Band 70.4039
Lower Bollinger Band 54.0663
Percent B (%b) 0.89
BandWidth 26.251424
MACD Line 3.0205
MACD Signal Line 2.5672
MACD Histogram 0.4533
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 70.1500
Resistance 3 (R3) 70.0400 69.4100 69.8900
Resistance 2 (R2) 69.4100 69.0127 69.4650 69.8033
Resistance 1 (R1) 69.0000 68.7673 69.2050 69.1100 69.7166
Pivot Point 68.3700 68.3700 68.4725 68.4250 68.3700
Support 1 (S1) 67.9600 67.9727 68.1650 68.0700 67.4634
Support 2 (S2) 67.3300 67.7273 67.3850 67.3767
Support 3 (S3) 66.9200 67.3300 67.2900
Support 4 (S4) 67.0300